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Craniofacial disorders present markedly complicated problems in reconstruction because
of the complex interactions of the multiple, simultaneously affected tissues. Regenerative
medicine holds promise for new strategies to improve treatment of these disorders. This
review addresses current areas of unmet need in craniofacial reconstruction and empha-
sizes how craniofacial tissues differ from their analogs elsewhere in the body. We present
a problem-based approach to illustrate current treatment strategies for various craniofacial
disorders, to highlight areas of need, and to suggest regenerative strategies for craniofacial
bone, fat, muscle, nerve, and skin. For some tissues, current approaches offer excellent
reconstructive solutions using autologous tissue or prosthetic materials.Thus, new “regen-
erative” approaches would need to offer major advantages in order to be adopted. In other
tissues, the unmet need is great, and we suggest the greatest regenerative need is for
muscle, skin, and nerve. The advent of composite facial tissue transplantation and the
development of regenerative medicine are each likely to add important new paradigms to
our treatment of craniofacial disorders.
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INTRODUCTION
As the field of regeneration biology progresses, new strategies
will develop for treating craniofacial disorders. Craniofacial dis-
orders are unique in that they affect multiple tissues simulta-
neously and occur across the full spectrum of patient age and
development. Treatments for craniofacial disorders have advanced
remarkably over the previous century. However, as with all recon-
structive approaches, these treatments remain imperfect. The hur-
dles remaining are generally related to improving our ability to
faithfully “replace like with like” and to minimize and eliminate
treatment-associated morbidity. The nascent field of regenerative
medicine offers promise to achieve some of these goals.
Regeneration is a specific process, different from “healing.” For
the purpose of this review, “regeneration” refers to the replace-
ment of human cells or tissues by like cells, reestablishing the
original form and function (Mason and Dunnill, 2008). The term
regeneration refers to different mechanisms in different tissues.
Regeneration may involve the proliferation and differentiation of
stem cells within tissue (Greenow and Clarke, 2012; King and New-
mark, 2012). For example, this type of regeneration occurs in skin
after partial thickness burn injury. Regeneration can also refer
to distinct processes, such as axonal regeneration in peripheral
nerves, that does not involve direct cell division and prolifera-
tion, but are reliant upon supporting cells for regeneration to
occur (Zochodne, 2012). In contrast to regeneration, the healing
of injuries in humans replaces injured tissue with a collagen-dense
scar. In healing, the resultant tissue differs from the native tissue in
gross and histologic appearance, strength and stiffness, and func-
tion (e.g., scarred muscle has diminished contractility, and scarred
skin has diminished sensation and sweating).
A number of evolutionary hypotheses exist as to why adult
mammals heal by scar formation after injury, while certain other
vertebrates such as salamanders have a remarkable ability to
regenerate solid tissues, including complete limbs, without scar.
In mammals, including humans, significant regenerative capac-
ity exists primarily during fetal and perinatal development. One
hypothesis is that healing by scar formation conferred an evo-
lutionary survival advantage in mammals. The rapid deposition
of fibrotic tissue to seal a wound prevents infection and pro-
tects vital structures, but also may actively prevent regeneration
(Brockes and Kumar, 2008; Gurtner et al., 2008). In support of
this, inhibiting the fibrotic response after spinal cord injury in
mice permits axonal regeneration (Stichel et al., 1999; Klapka
and Muller, 2006). Another proposed teleological hypothesis is
that mammals have evolved more stringent negative regulation
of cellular growth control as part of advanced tumor suppres-
sor mechanisms. This could confer a survival advantage at the
expense of regenerative capacity (Blau and Pomerantz, 2011). A
logical extension of such observations is that regenerative capacity
may have been lost in higher organisms in favor of tissue stability,
avoidance of infection, cancer prevention, and longevity. How-
ever, an alternate hypothesis is that regeneration was not lost as
mammals evolved, but rather that regeneration separately evolved
in certain species. Some evidence supporting this theory is the
discovery of specific proteins involved in regeneration that are
unique to salamanders (Garza-Garcia et al., 2010). It is possible
that each of these hypotheses is partly true. A better understand-
ing of the regenerative mechanisms of both lower vertebrates and
developmentally immature mammals may inform our approaches
to mammalian regeneration.
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Regenerative medicine has emerged as “the process of cre-
ating living, functional tissues to repair or replace tissue or
organ function lost due to age, disease, damage, or congeni-
tal defects” (http://report.nih.gov/NIHfactsheets/ViewFactSheet.
aspx?csid=62). Plastic and reconstructive surgery, and the cran-
iofacial subspecialty, is an old field of medicine with an almost
identical focus: repairing or reconstructing defects of form and
function in diverse tissues and patients (American Board of Plas-
tic Surgery, 2012). The purpose of this review is to discuss where
novel approaches to treat craniofacial conditions are most needed.
This review will examine how regenerative strategies may improve
upon current reconstructive practices. We consider the spectrum
of craniofacial disorders and how craniofacial tissues differ from
their analogs elsewhere in the body in function and embryologic
origin. We then present a problem-based approach to illustrate
current strategies for treatment, as well as what we consider the
most critical regenerative goals for craniofacial bone, fat, muscle,
nerve, and skin. Regenerative strategies for teeth, cartilage, sali-
vary glands, and sensory organs contributing to sight, hearing,
smell, and taste, all of importance to craniofacial medicine, are
beyond the scope of this review and are addressed in other excel-
lent reviews (For teeth, see: Mao et al., 2006; Huang et al., 2009;
Yildirim et al., 2011; Machado et al., 2012; for auricular cartilage,
see: Bichara et al., 2012; for salivary glands, see: Kagami et al., 2008;
for retina, see: Lamba et al., 2008; Singh and MacLaren, 2011; for
inner ear, see: De Felipe et al., 2011; Okano and Kelley, 2012; for
olfactory, see: Goldstein and Lane, 2004; Costanzo and Yagi, 2011;
for taste, see: Miura and Barlow, 2010). In some cases, our current
treatments and innate healing responses provide adequate solu-
tions. In other craniofacial disorders, regenerative medicine may
lead to improved tissue appearance and function, and decreased
morbidity.
THE COMPLEX FUNCTIONS OF CRANIOFACIAL TISSUES IN
HEALTH AND DISEASE
The face has a remarkably complex function in humans. The tis-
sues of the face receive and transmit tremendous amounts of
information each day. The cranial nerves receive information from
all five senses. Muscles of the face respond to stimuli with complex
expressions, and are responsible for rapid movements of the eyes
and forceful movements of the jaw in mastication. In addition,
bones of the skull protect the brain and orbits. Facial appear-
ance is a fundamental component of individuality. Craniofacial
disorders lead to abnormalities in a wide range of patients and
tissues that disrupt these functions (Table 1). These problems
can be physically, emotionally, and socially disabling. Given the
complex nature of craniofacial function and disease, recreating
these tissues is a daunting task. Even the most sophisticated of our
current approaches do not fully reproduce the fine complex func-
tion and form that is the hallmark of craniofacial anatomy and
physiology. Newer regenerative approaches may offer paradigm
changes toward this goal. In developing regenerative strategies,
the tissues must be considered individually, as well as in combina-
tion with each other. Some endogenous tissue repair mechanisms
may provide solutions for regenerating tissues. In other cases,
true regeneration may not be necessary to achieve an excellent
outcome.
THE UNIQUE EMBRYOLOGIC ORIGINS OF CRANIOFACIAL
TISSUES AND THE ROLE OF NEURAL CREST CELLS
One reason that craniofacial disorders manifest differently from
disorders in the trunk and extremities may relate to the dis-
tinct embryologic origins of the craniofacial tissues. They sub-
sequently have distinct gene expression patterns and physiology.
Understanding these differences may be important for induc-
ing regeneration of craniofacial tissues. Studies of regeneration
across phyla suggest that reactivation of developmental signal-
ing pathways is a common theme (reviewed in Sanchez Alvarado
and Tsonis, 2006). Therefore, regeneration might be expected
to recapitulate the complex interactions of the ectoderm, meso-
derm, and endoderm that form the pharyngeal arches, as well as
the generation of critical structures by cranial neural crest cells
(Figure 1).
Cranial neural crest cells have unique features and play a crit-
ical role in the development of the face and head (Le Lièvre and
Le Douarin, 1975; Gitton et al., 2010; Grevellec and Tucker, 2010;
Cordero et al., 2011; Le Douarin and Dupin, 2012). The dentin-
secreting odontoblasts of teeth are exclusively derived from cranial
neural crest cells (Lumsden, 1988). While other populations of
neural crest cells also contribute to neurons, ganglia, and pigment
cells, only cranial neural crest cells are able to form cartilage and
bone (Couly et al., 2002; Le Douarin et al., 2007; reviewed in Hall
and Gillis, 2012). Most bones of the body are derived from the
mesoderm and ossify by endochondral ossification. In contrast,
the bones of the face and much of the cranial vault originate from
neural crest cells and undergo intramembranous ossification dur-
ing development (Couly et al., 1993; Jiang et al., 2002; Levi et al.,
2012). Cranial neural crest cells are also the primary contributor
to fibro adipogenic progenitor cells in the face, whereas fibro adi-
pogenic progenitor cells are of mesodermal origin in the trunk
(Lemos et al., 2012). Fibro adipogenic progenitor cells give rise
to adipocytes, contribute to fibrofatty infiltration in tissues, and
some reports suggest that they may function in concert with mus-
cle precursor cells to facilitate muscle differentiation after injury
(Joe et al., 2010).
Since neural crest cells exert a major influence on craniofa-
cial development, are they also mediators of healing potential and
disease? If this were the case, one implication would be that engi-
neered or transplanted tissue replacements would either need to be
derived from neural crest sources, or be able to derive the pheno-
types and perform the functions of cranial neural crest derivatives.
The following examples illustrate these considerations. In the skull,
it is possible that the unique origin and ossification of craniofacial
bones from neural crest cells may be optimized for the massive
skull growth occurring in infancy (Jiang et al., 2002). It has also
been suggested that the origin of different skull bones influences
their healing potential. For example, frontal bone derived from
neural crest cells regenerated to fill a defect more rapidly than
parietal bone derived from paraxial mesoderm in both juvenile
and adult mice (Quarto et al., 2010). In contrast to the differences
seen in bone, fibro adipogenic progenitor cells from both the face
and trunk appear to exhibit a similar phenotype, differentiation
potential, and response to muscle damage despite differences in
gene expression (Lemos et al., 2012). Finally, the preference for cer-
tain diseases to uniquely affect the face may be attributed to defects
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Table 1 | Examples of craniofacial disorders and corresponding unmet “regenerative” needs.
Disease Tissue defects Current strategies Regenerative need
CONGENITAL
Craniosynostosis Early bony suture fusion, aberrant skull
growth if untreated
Successful bone regeneration after
surgery if treated before age one
Promoting complete regeneration of the
skull after surgery in all cases
Cleft lip/palate Deficiency of palatal fusion including bone,
muscle, and mucosa
Staged surgical repairs Mucosa, without scarring that limits bone
growth and causes maxillary deficiency
Secondary deformities from inadequate
growth after surgical intervention
Alveolar bone grafting Elimination of bone graft donor site
morbidity
Craniofacial
microsomia
Deficient bone and soft tissue development
of the face
Distraction osteogenesis
Fat grafting
Free tissue transfer
Multiple structures are hypoplastic: bone,
muscle, skin, cartilage, nerve
Achieving normal appearance
Microtia Deficient and abnormal ear cartilage
formation
Reconstruction with rib graft or
alloplastic material
A functional reproduction of a normal ear
without requiring a rib graft, and with less
scarring
Moebius Bilateral facial paralysis due to
underdevelopment of cranial nerves
Free tissue transfer Cranial nerve generation, or regeneration
Development of target muscles
TRAUMATIC
Burn Need for full skin coverage Split-thickness skin grafting Regenerated complete skin organ
(epidermis, dermis, and appendages)
Secondary deformities associated with scar
contracture and loss of cartilaginous support
Fat and skin grafting to
contractures
Supple, well-vascularized skin replacement
with underlying cartilage framework
Fractures Bone gaps occasionally present due to
trauma, malunion, or non-union
Fixation Regeneration of large defects
Bone grafts
Soft tissue atrophy
or tissue loss due to
injury
May affect fat, muscle, skin, cartilages,
mucosa, or nerves
Fat grafting “Composite tissue” regeneration to
replace subtle and complex form and
function
Free tissue transfer
Skin grafting
Face transplantation
ONCOLOGIC
Oropharyngeal or
other facial cancers
Bone, soft tissue, muscle, and nerve may be
radically resected
Free tissue transfer “Composite tissue” regeneration to
replace subtle and complex form and
function
Radiation Negatively affects skin and soft tissue
elasticity and healing; causes
osteoradionecrosis
Fat grafting
Bone grafting
Skin regeneration
Bone regeneration
IDIOPATHIC
Bell’s palsy Facial nerve paralysis Micro-neurovascular free muscle
transfer
Nerve and muscle regeneration to achieve
complex function of multiple musclesSecondary muscle denervation and atrophy
Parry-Romberg/
progressive
hemifacial atrophy
Progressive loss of soft tissue, nerve, muscle Fat grafting Fat regeneration
Nerve and muscle regeneration
AGING
Fat atrophy Fat grafting Rejuvenation of skin quality
Loss of skin elasticity Skin resurfacing Rejuvenation of fat quantity and location
Changes in skin pigmentation
in cranial neural crest cell number or function. Neural crest cells
have been directly associated with several craniofacial malforma-
tions. Treacher Collins syndrome (OMIM 154500), characterized
by facial bone hypoplasia, ear deformities, and colobomas of the
eyelids, is caused by mutations in TCOF1 that results in a decrease
in the number of neural crest cells (Trainor, 2010). In CHARGE
syndrome (OMIM 214800), mutations in CHD7 are implicated
in affecting neural crest cell migration. Dysfunction of neural
crest cell migration is also implicated in Waardenburg syndrome,
type 2D (OMIM 608890) and Mowat–Wilson syndrome (OMIM
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FIGURE 1 | Cranial neural crest cells have unique contributions to tissues
of the face and head. Ectodermal derivatives are in blue, mesodermal
derivatives in red, and endodermal derivatives in purple. In green are the
components of these tissues that develop primarily from cranial neural crest
cells. In the face and head, cranial neural crest cells contribute to bone,
cartilage, and fat, while this is not the case in the trunk and extremities. While
all of the craniofacial muscles arise from the mesoderm (red), note that
different muscle groups develop from different regions of the mesoderm.
References to the developmental origins of the structures in this figure are
located throughout the manuscript.
235730; reviewed in Cordero et al., 2011). Neural crest cells may
also be involved in fat dystrophies that uniquely affect the face, such
as congenital infiltrating lipomatosis (Chen et al., 2002). Other
lipodystrophies such as Dunnigan–Kobberling syndrome (OMIM
151660) affect the trunk and extremities, but spare the face. These
conditions highlight that a somatic mutation results in distinct
phenotypes among craniofacial and body tissues and reinforces
the notion that faithful generation or engineering of craniofacial
structures may require unique building blocks.
DIFFERENT SETS OF CRANIOFACIAL MUSCLES ARISE FROM
DIFFERENT REGIONS OF MESODERM
Like other muscles, craniofacial muscles are also derived from
mesoderm, however, groups of craniofacial muscles arise from dis-
tinct regions of mesoderm (reviewed in Noden and Francis-West,
2006; Figure 1). Somitic mesoderm forms much of the muscle of
the trunk and extremities, but in the face, only the muscles of the
tongue and anterior neck are derived from the somites. In contrast,
the muscles of mastication and facial expression arise from pha-
ryngeal arch mesoderm, where they develop in close association
with the neural crest-derived bones and tendons (Grenier et al.,
2009). Finally, extraocular muscles arise from anterior paraxial
and prechordal mesoderm (Noden and Francis-West, 2006; Sam-
basivan et al., 2009). The differences in embryologic origin of face
muscles and body muscles are accompanied by differences in the
signaling molecules that trigger muscle differentiation in these
locations (Sambasivan et al., 2009; reviewed in Kelly, 2010).
Similarly, satellite cells, the tissue-resident muscle stem cells,
have different gene expression patterns and characteristics in the
face compared with the body. For example, in the trunk, satel-
lite cells express Pax7 and Pax3 (Relaix et al., 2005). However,
only Pax7 is expressed in the muscles of the face (Harel et al.,
2009; Otto et al., 2009; Kelly, 2010). Satellite cell frequency in
muscle fibers also differs. Extraocular, laryngeal, and masseteric
muscles have a greater frequency of satellite cells than other
skeletal muscles (McLoon et al., 2007). Furthermore, uninjured
extraocular and laryngeal muscles contain significant popula-
tions of activated satellite cells under normal conditions. These
muscles have a high level of basal regenerative activity, and are
resistant to the myotoxicity of local anesthetics (Kalhovde et al.,
2005; McLoon et al., 2007). Determining whether these differ-
ences in satellite cells are intrinsic and how they contribute to
regenerative potential is unclear, however. In one comparison of
satellite cells between the masseter and limb, there was no dif-
ference with regards to myogenic potential in vitro (Grefte et al.,
2012). Another study showed that masseteric satellite cells differ-
entiated more slowly, but contributed to limb muscle regeneration
in vivo (Ono et al., 2010). Limb satellite cells have not been studied
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in models of facial muscle injury and so the prospects for using
limb muscle stem cells to regenerate facial muscles are not yet
defined.
Assessment of regenerative potential from satellite cells must
include analysis of both the satellite cell proliferative response
and the regenerated muscle fiber type and function. Skeletal mus-
cles and craniofacial muscles differ in the myosin isoforms that
they express. The muscle fibers of the face express embryonic
and neonatal myosin in addition to adult myosin isoforms. Occa-
sionally, facial muscles express multiple myosin isoforms within a
single muscle fiber, which has not been observed in other muscles
(Stal, 1994; Porter, 2002). Distinct myosin isoforms and a greater
number of mitochondria in craniofacial muscle cells may con-
tribute to the resistance to fatigue that craniofacial muscles exhibit.
Assuming these unique characteristics of craniofacial muscles are
important to their structure or function, recreating these nuances
using body muscle stem cells may not be straightforward.
Finally, craniofacial muscles exhibit different susceptibility to
pathological conditions. In diseases such as amyotrophic lateral
sclerosis (OMIM 105400), the extraocular muscles are not affected.
Other craniofacial muscles such as the masseter are affected less
severely than body skeletal muscles (Valdez et al., 2012). In con-
trast, diseases such as myasthenia gravis (OMIM 254200), ocu-
lopharyngeal muscular dystrophy (OMIM 164300), and chronic
progressive external ophthalmoplegia (OMIM 157640) preferen-
tially affect the extraocular and facial muscles (Benveniste et al.,
2005; Greaves et al., 2010).
With regards to regenerative strategies for muscles, the impor-
tance of the differences between craniofacial and body muscles in
developmental origins, satellite cells, and contractile elements is
unclear. The phenotypic differences between extraocular, masse-
teric, and limb skeletal muscle may be important for regenerating
muscle for craniofacial diseases. It is unknown whether satel-
lite cells from the same muscle subset are required to achieve
the same phenotype, or whether transplanted satellite cells will
adopt the phenotype of their new environment. The answers
to these questions could have critical implications for the treat-
ment of muscle-group specific dystrophies. For example, if satellite
cells retain adequate intrinsic plasticity, one potential regenerative
strategy would be to use autologous transplantation of cells from
unaffected or less affected muscle groups to more severely affected
muscles. Similarly, satellite cells could be harvested from expend-
able muscles of the body to regenerate craniofacial muscle defects,
with the goal of achieving function in addition to form.
Innervation to the different groups of facial muscles is by
the cranial nerves, which have a highly conserved organization
among vertebrates. Unlike spinal motor neurons, stemming from
columns along the spine, cranial motor neurons extend from dis-
crete nuclei in the midbrain and hindbrain (reviewed in Gilland
and Baker, 2005; Guthrie, 2007). Each cranial motor nerve inner-
vates a large number of distinct muscles, many of which can
be controlled individually. Some cranial nerves are strictly effer-
ent motor neurons, including cranial nerves III, IV, and VI to
the extraocular muscles and cranial nerve XII controlling tongue
movement. Other cranial nerves are mixed with motor and sensory
components. These “branchiomeric” nerves have sensory ganglia
that are formed by contributions from neural crest cells (Figure 1),
and motor components that extend to striated muscles as well as
to parasympathetic ganglia (cranial nerves III, VII, IX, and X), and
the mechanosensory hair cells of the inner ear (cranial nerve VIII;
reviewed in Guthrie, 2007). Also unique in craniofacial nervous
system development is the development of the sensory organs from
the cranial placodes (reviewed in Streit, 2004; Schlosser, 2006).
Despite the unique organization and development of the cranial
nerves, however, they appear to be functionally similar to other
peripheral nerves of the body and there is no known difference in
their regenerative capacity.
In the following sections, we present clinical vignettes to
illustrate typical craniofacial disorders and how regenerative
approaches may be applied in order to treat the conditions.
TREATMENT OPTIONS FOR CRANIOFACIAL BONE
RECONSTRUCTION DEPEND ON THE CHARACTERISTICS OF
THE DEFECT AND THE PATIENT’S AGE
CLINICAL VIGNETTES
A boy presented with a large post-operative cranial defect
after treatment for coronal suture craniosynostosis (Figure 2).
Although defects of this size usually are replaced by regenerated
bone in infants, the chance of regenerating this type of defect is
low in children older than 2 years. This patient was 3-years-old,
and he therefore required reconstruction with prosthetic material.
Another infant with multiple suture synostosis had elevated
intracranial pressure due to premature closure of the cranial
FIGURE 2 | A computed tomography scan demonstrates a large defect
(arrow) in the left frontoparietal skull of a 3-year-old boy. This required
reconstruction with alloplastic materials or large bone grafts.
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sutures (Figure 3A). To increase the size of the posterior cra-
nial vault and decrease the intracranial pressure, the child was
treated with distraction osteogenesis. After creating osteotomies
and placing a distraction device, the occipital bone was gradually
advanced posteriorly and new bone gradually regenerated to fill
the defect. Regeneration is extensive, but calcification incomplete,
after 4 months (Figure 3B).
Craniofacial bones are responsible for bearing the forces asso-
ciated with mastication, supporting the structures of the face, and
protecting the brain and orbits. In adult mammals, bony defects
of a critical-size will not regenerate normally and typically require
reconstruction. Critical-size bony defects [8 mm in rats (Takagi
and Urist, 1982), 15 mm in rabbits (Dodde et al., 2000), and 30 mm
in sheep (Reichert et al., 2009)] will not regenerate over the lifetime
of the adult animal. Reconstruction of such skull defects typically
requires alloplastic materials or bone grafting.
In contrast to adults, infants successfully regenerate bone in
large cranial defects. One common example in which this occurs
is after surgical treatment for craniosynostosis. In this operation,
large bony gaps are created to expand the skull and permit brain
growth. Remarkably, when cranial vault expansion is performed
before one year of age, normal cranial bone is regenerated to fill
the large iatrogenic defects. In the clinical scenario described in
Figure 2, the patient required alloplastic reconstruction given his
relatively advanced age of 3 years. The mechanisms behind age-
related differences in skull regenerative capacity remain poorly
understood. Cranial bone regeneration is thought to occur by
osteoinduction from the underlying dura (Hobar et al., 1993).
Therefore, identifying how dural signaling changes after infancy
would presumably shed light on how the regenerative capacity of
cranial bone changes with age. Currently available treatments to
replace bone meet the functional requirements of cranial bone.
However, regenerative strategies could theoretically improve out-
comes in certain scenarios by preventing the need to use prosthetic
materials or obviating complications such as failed bone grafts,
infection, and donor site morbidity. One theoretically attrac-
tive avenue would be to restore the mechanisms that allow full
FIGURE 3 | Computed tomography scans of an infant with multiple
suture synostosis preoperatively (A) and 4 months after distraction of
the posterior cranial vault (B). The distraction footplates have been
gradually separated by a distance of 25 mm and evidence of calcified bony
regenerate is present between the footplates (arrow).
regeneration of cranial bone in infants and apply these principles
to older patients (Wan et al., 2008).
A highly effective treatment for craniofacial bony defects and
deficiencies is distraction osteogenesis, which induces bone gen-
eration (reviewed in McCarthy et al., 2001). In this procedure, an
osteotomy is made in the area of desired bone generation, and
early fracture healing leads to callous formation. The fibrovascu-
lar matrix that comprises the callus is then lengthened by gradual
mechanical strain in the desired direction of growth. Osteoblasts
secrete osteoid to fill the bony gap, and after complete miner-
alization and bony remodeling, the histology of this new bone
resembles that of normal bone (Alman et al., 2011). Strength
of the bone after distraction osteogenesis, however, was approxi-
mately forty percent less than normal bone when studied in the
mandible (Schwarz et al., 2010). This technique, first developed
in long bones, has been effectively used to lengthen the mandible
in cases of mandibular hypoplasia (Ow and Cheung, 2008), or
expand the cranial vault in cases of complex craniosynostosis
(Figure 3; Taylor et al., 2012). While distraction osteogenesis was
initially developed for linear vectors of growth, strategies are being
developed to apply distraction to the complex shapes of the facial
skeleton,via use of multi-directional distraction devices (Schendel,
2011).
Distraction and bone grafting offer very effective treatments
for craniofacial bony deficiencies. In fact, one may argue whether
additional “regenerative” approaches are warranted. The strongest
argument in favor of developing new approaches relates to the
morbidity of the current solutions, which can be considerable
with distraction and procedures that involve harvesting of bone
grafts. Another important issue of relevance is the need for
approaches that produce bone that will grow with the patient.
Such advances would eliminate the need to delay or repeat
treatments.
Additional strategies for regenerating bone include the use
of growth factors or stem cells. Bone morphogenetic proteins
(BMPs) have enhanced effective osteogenesis and improved heal-
ing potential in critical-size calvarial defects (Sato and Urist,
1985; Lindholm et al., 1988). BMPs were approved for use in
the US in 2004, with approved indications including tibial frac-
tures, sinus augmentations, alveolar ridge augmentations, and
lumbar spinal fusions. The complication rate associated with the
use of BMPs has recently called into question the use of BMP,
however (Williams et al., 2011). This highlights the complexity
associated with “targeted molecular” approaches to induce bone
formation. Other growth factors such as transforming growth
factor-β (TGF-β), and platelet-derived growth factor (PDGF)
may also contribute to improved regeneration potential in the
appropriate environment (Schilephake, 2002). Given the unique
embryologic origins of cranial bone, it is reasonable to assume
that the response of cranial osteoblasts to particular growth fac-
tors could differ from the response of long bone osteoblasts.
Furthermore, the importance of mechanical forces in bone heal-
ing may play a large role in the healing potential of bone
given the unique processes by which cranial and axial skeletal
bone form (i.e., endochondral vs. intramembranous ossifica-
tion). These unique characteristics of cranial bone compared with
the axial skeleton must be taken into account as sophisticated
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methods of inducing bone regeneration are investigated and
developed.
With regards to cell-based approaches, both bone marrow-
derived mesenchymal stem cells and adipose-derived mesenchy-
mal stem cells have been demonstrated to form bone in vitro
(Jaiswal et al., 1997; Zuk et al., 2001; Dragoo et al., 2003;
Hicok et al., 2004) and in vivo when delivered in conjunc-
tion with scaffolds. Some studies demonstrated that the regen-
erated bone was histologically comparable to surrounding bone
(Cowan et al., 2004; reviewed in Zuk, 2008). A variety of pre-
cursor cells can be differentiated into osteogenic cells in vitro
(reviewed in Mao et al., 2006; Seong et al., 2010). Current
research also attempts to further understand how different com-
binations of scaffolds, cells, and growth factors may improve
bony regeneration of craniofacial structures. Despite the large
body of basic science evidence supporting some of these strate-
gies, few have made their way into common clinical practice.
Clinical trials are underway investigating the use of particu-
lar bone marrow fractions to induce or enhance alveolar bone
regeneration with subsequent dental implants (Kaigler et al.,
2012; ClinicalTrials.gov ID NCT01616953). However, because
many successful clinical tools are already available, morbid-
ity is acceptable, and outcomes are generally good, these new
approaches would need to present much improved function,
safety, cost, and decreased morbidity in order to be widely
adopted.
STABLE RESTORATION OF FACIAL CONTOUR BY
TRANSPLANTATION OF ADIPOSE TISSUE
CLINICAL VIGNETTE
A man with HIV lipodystrophy presented with severe hollowing
in the cheeks due to atrophy of the malar fat pads (Figure 4A).
Another man with a remote history of trauma to the right side of
his face developed progressive soft tissue atrophy leading to severe
facial asymmetry (Figure 4C). Both men underwent several ses-
sions of autologous fat grafting to restore more normal volume
and contour to their faces (Figures 4B,D).
Fat grafting for both reconstruction and rejuvenation of the
aging face has increased in popularity in the last 10 years, but fat
grafting has been used in various forms for many decades. Autolo-
gous fat grafting has a number of theoretical and observed advan-
tages that are rapidly making it the preferred approach for facial
augmentation. The use of autologous living tissue has the follow-
ing benefits: incorporation of a living graft into the surrounding
tissues, minimal chance of infection, and a natural appearance and
feel that is distinctly better than implants and most fillers. Remark-
ably, grafted fat not only creates volume, but its integration as a
living tissue can result in beneficial interactions with surrounding
tissues. For example, grafting of fat into an area of contracted,
and/or irradiated, skin results in softening, improvements in elas-
ticity, and increased health of the overlying and surrounding skin
(Klinger et al., 2008; Mojallal et al., 2009; Phulpin et al., 2009). The
mechanism by which grafted fat improves the quality of adjacent
skin is unknown, but may involve improved vascularization or
secreted paracrine factor effects. In contrast, prosthetic materials
or fillers can have undesirable interactions with the surround-
ing tissue. At best, these materials are relatively inert. However,
FIGURE 4 | Autologous fat transfer to treat facial soft tissue deficiency.
A man with severe HIV lipodystrophy [(A), preoperative photo] underwent
serial fat grafting to both malar regions [(B), post-operative photo]. This
restored normal facial contour and a more youthful appearance. (C)
Preoperative photo of a patient with post-traumatic soft tissue atrophy on
the right side of his face had long lasting improvements in facial symmetry
after several sessions of fat grafting from the abdomen to the right cheek
and jaw region [(D), post-operative photo). In both cases lipoaspirate was
processed by brief centrifugation and passage through a syringe. The cells
within the lipoaspirate were not altered or enriched for specific cell types.
Multiple injections of very small quantities of fat were used in each
treatment.
as a foreign material, fillers are susceptible to causing inflamma-
tory reactions, allergies, or infection (reviewed in Hirsch and Stier,
2008).
Another challenge with soft tissue augmentation relates to the
duration of the augmentation effect. Implants can be perma-
nent in the absence of complications. However, implants may also
require repositioning or replacement over time and are susceptible
to capsular contracture. Synthetic or natural fillers are tempo-
rary and typically last only several months. These fillers require
repeated treatments and considerable associated financial cost.
Long-term studies have now shown that autologous fat grafting
can last decades or longer (reviewed in Coleman, 2006a,b), offer-
ing another major benefit over the impermanence of synthetic or
natural fillers. At present, the most important issue facing the wide
adoption of fat grafting, however, is the wide variability in tech-
niques and results among different practitioners. After fat grafting,
the retention of fat volume ranges from 20 to 90% in various stud-
ies (reviewed in Wetterau et al., 2012). Furthermore, the biology of
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fat grafting with regards to the stem cell sources of adipocytes, how
engraftment occurs, and the factors that influence graft retention
are not yet fully understood (Bucky and Percec, 2008).
Adipose tissue contains a robust source of adipose stem cells,
and has a high rate of endogenous turnover. Approximately 50%
of adipocytes in the body are replaced every 8 years (Spalding
et al., 2008), although this has not been studied in craniofacial
fat specifically. Preadipocytes are capable of self-renewal and dif-
ferentiation into white adipose tissue, but are committed to a
single cell fate prenatally or in the early postnatal period (Tang
et al., 2008). In addition to preadipocytes, the stromovascular
fraction of lipoaspirates contains cell populations capable of dif-
ferentiation into fat, bone, muscle, and cartilage in vitro (Zuk,
2008). However, the precise relationship of these cells to com-
mitted preadipocytes is not entirely clear (reviewed in Cawthorn
et al., 2012). Some clinicians advocate the isolation of these cells
in the stromovascular fraction to augment the lipoaspirate in fat
grafting (Yoshimura et al., 2009), based on the notion that adipose-
derived mesenchymal stem cells in the stromovascular fraction
secrete angiogenic growth factors, which may increase graft sur-
vival. Other growth factors such as insulin, insulin-like growth
factor-1 (IGF-1; Yuksel et al., 2000), and platelet-rich plasma
(Nakamura et al., 2010; Pires Fraga et al., 2010) have also been
added to fat grafts to improve retention, with greater final fat graft
weight, and vascularization as compared with untreated grafts in
animal models.
Clinically, currently available fat grafting strategies are very
successful for the treatment of contour deformities from lipodys-
trophies and rejuvenation of the aging face. The observed stability
of fat transfer over the long-term strongly suggests that fat regen-
eration occurs within the graft, with continued differentiation of
adipocytes from preadipocytes and normal fat turnover. This nor-
mal tissue homeostasis involving the continuous generation of
new fat cells is evidence of the existence of a tissue-resident stem
cell for fat. It follows that current fat transfer techniques are, in
fact, transferring adipose stem cells along with adipocytes and
other cell types. Fat grafting, therefore, largely fits the definition
of regenerative medicine. Augmenting a fat graft with particu-
lar purified cell fractions or growth factors may hold promise for
improving predictability and retention, although clear superiority
of these techniques compared with traditional methods has not
been shown. Clinical trials are underway to more critically evaluate
whether concentrating the stromovascular fraction in lipoaspi-
rates will be better than traditional methods in treating post-
traumatic soft tissue deformities of the face (ClinicalTrials.gov ID
NCT01564524).
The cellular mechanisms contributing to lipodystrophies and
aging are not fully understood, however overcoming the gaps in
knowledge about fat biology and pathology would potentially
allow direct regeneration of fat without grafting from other sites.
Currently adipose precursor cells have been shown to form fat
in vitro (Kim et al., 2007; Wu et al., 2012), but direct fat differenti-
ation in vivo has not been reported. A clinical trial to assess efficacy
of adipose-derived stem cell injections in progressive hemifa-
cial atrophy (ClinicalTrials.gov ID NCT01309061) is in progress.
At present, however, the indications for fat grafting continue to
expand and clinical results continue to improve.
PERMANENT DIPLOPIA AFTER INJURY TO AN
EXTRAOCULAR MUSCLE
CLINICAL VIGNETTE
An elderly man suffered an orbital roof fracture that caused entrap-
ment of his left superior rectus muscle. This injury left him with
diplopia (double vision) and an inability to look upward with his
left eye (Figure 5). Despite release of the muscle from the fracture
fragments, the injury to the muscle was permanent due to muscle
fibrosis.
While reasonably good techniques exist for replacing bone and
fat, regenerating, repairing, or replacing functional muscle remains
a significant challenge. Although muscle transfers (called flaps)
have vastly improved our ability to treat a variety of tissue defects
over the past three to four decades, there remain major limitations
in the function that can be achieved. Strategies for addressing the
loss of fine muscle function, including the critical functions of
many small muscles of the face and head, are lacking. Myoblasts,
or muscle precursor cells, have been injected into injured muscle
in animal models and in patients with Duchenne muscular dys-
trophy to promote muscle regeneration (Rando and Blau, 1994;
Miller et al., 1997). However, myoblasts exhibit relatively poor sur-
vival and engraftment into the host tissue, and studies in mice now
clearly demonstrate the superiority of muscle stem cells (satellite
cells) in terms of their ability to engraft and regenerate muscle.
Satellite cells in the muscle, bone marrow-derived mesenchymal
stem cells, and adipose-derived mesenchymal stem cells have all
been shown have myogenic properties in vitro (Wakitani et al.,
1995; Zuk et al.,2001; Muguruma et al.,2003; Di Rocco et al.,2006).
However, mesenchymal stem cells have not demonstrated success-
ful regeneration in vivo (reviewed in Otto et al., 2009). Only satel-
lite cells have truly fulfilled the criteria of a stem cell for muscle.
Therefore, satellite cells currently show the most promise
in translational applications for functional muscle regeneration.
These adult muscle stem cells are capable of robust self-renewal,
differentiation into myoblasts, and formation of mature skele-
tal muscle fibers in response to injury (Bischoff, 1986; Zammit
et al., 2006; Cosgrove et al., 2009). Transplantation of intact single
myofibers into injured muscle leads to satellite cell renewal and
myofiber regeneration (Collins et al., 2005; Hall et al., 2010). Sin-
gle, prospectively isolated muscle stem cells have been transplanted
into mouse muscle, demonstrating self-renewal, expansion, and
FIGURE 5 |This man suffers from the inability to look upward with his
left eye after permanent injury to the left superior rectus muscle.
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differentiation into functional muscle fibers in vivo (Cerletti et al.,
2008; Sacco et al., 2008). Muscle stem cell transplantation has
resulted in correction of dystrophic phenotypes in mdx mice
(Sacco et al., 2010). Major remaining challenges include the trans-
lation of mouse satellite cell biology to humans, and overcoming
additional hurdles such as correction of genetic defects and ex vivo
satellite cell expansion.
As demonstrated by the example of extraocular muscle injury
(Figure 5), regeneration of craniofacial muscle is an area of great
clinical need. Ideal treatments might involve transplantation of
autologous satellite cells from an area of excess to an area of need.
Before it becomes a clinical reality, we must better understand the
differences between satellite cell populations. Are they capable of
regenerating only their native muscle phenotype? Or is it possi-
ble that limb satellite cells could effectively regenerate extraocular
muscle?
REANIMATING THE FACE: REGENERATIVE STRATEGIES FOR
NERVE AND MUSCLE IN FACIAL PARALYSIS
CLINICAL VIGNETTE
A girl with congenital right-sided facial paralysis was treated with
an innervated muscle flap to restore a functional smile (Figure 6).
This procedure involved free gracilis muscle micro-neurovascular
transfer to the face. The muscle was innervated by the ipsilateral
nerve to the masseter. With clenching of the teeth, the gracilis mus-
cle would contract and elevate the oral commissure to recreate a
natural symmetric smile.
Injury to the facial nerve leads to two tissue problems. First,
injury to the nerve leads to denervation of the target muscles.
Second, denervation of the muscles over the long-term leads to
muscular atrophy and loss of function (Kobayashi et al., 1997).
After injury, axons degenerate in response to denervation (Sunder-
land and Bradley, 1950). Peripheral nerves are unable to regenerate
the cell body, but axons are able to regrow from existing cells
at a rate of 1 mm/day in humans. For this reason, in cases of
nerve transection or other injury that will not recover on its own,
current treatments aim to restore continuity of the nerve sheath
and guide axonal regeneration, either by primary nerve repair or
nerve grafting (reviewed in Siemionow et al., 2010). Successful
FIGURE 6 | (A) A girl with congenital right-sided facial paralysis
demonstrates asymmetry with smiling. She was treated with free gracilis
muscle transfer. (B) The muscle is inset to the zygoma and the oral
commissure. The new vascular supply to the muscle is shown on the blue
background. The muscle was innervated by the nerve to masseter (not
shown).
reinnervation can occur, but is dependent upon the location of
the injury and the timing of the repair. Improving axon growth
in both acute and chronic nerve injury is critical to improving the
functional potential of regenerating peripheral nerves.
Schwann cells play an important role in supporting axon
growth. They closely accompany the axons as they grow. Schwann
cells migrate distally from the zone of injury ahead of the regen-
erating axon, as if clearing a path for the axon. Schwann cells also
secrete laminin, fibronectin, and other factors that facilitate axonal
growth (reviewed in Zochodne, 2012). However, denervation of
the nerve stump leads to loss of Schwann cells (Sulaiman et al.,
2002), and limits regeneration. Therefore, one approach to sup-
porting peripheral nerve regeneration is to transplant Schwann
cells. Schwann cells have been expanded in culture and trans-
planted to chronically denervated rat tibial nerves. These cultured
Schwann cells increased axonal regeneration and muscle reinner-
vation (Walsh et al., 2010). Similarly, adipose-derived stem cells
have been differentiated into a Schwann cell phenotype for this
purpose (Kingham et al., 2007), and demonstrated myelination
and improved nerve regeneration after transplantation distal to
a sciatic nerve injury in a rat (Tomita et al., 2012). While these
approaches need to be further refined and verified with regards
to functional outcomes, Schwann cell transplants may prove suc-
cessful for peripheral nerve regeneration (reviewed in Walsh and
Midha, 2009).
Several challenges must be overcome in peripheral nerve axonal
regeneration. First, the rate of growth remains very slow. Find-
ing ways to accelerate the axonal growth rate would decrease the
amount of degeneration that both the peripheral nerve axon and
the target muscle experience. It is known that advanced age can
slow both axonal regeneration (reviewed in Verdu et al., 2000)
and collateral sprouting (Kovacic et al., 2010), however there are
presently no known mechanisms for accelerating axonal growth.
Second, there are innate inhibitory interactions that occur at the
regenerating axon (reviewed in Zochodne, 2012). Studying how
to overcome these inhibitory pathways to promote axonal growth
will also be important in optimizing peripheral nerve regenera-
tion. Second, an additional major challenge is to accurately control
the direction of axonal growth. This is a critical problem, noted in
particular after inflammatory injury to the facial nerve, as occurs
in Bell’s palsy. In patients with Bell’s palsy, synkinesis, or abnor-
mal simultaneous muscle movement, can occur due to aberrant
regeneration of the nerve axons. Using either physical or molecu-
lar guides to ensure an axon reaches its appropriate target would
have tremendous clinical implications.
In addition to the problems associated with axonal regrowth are
the subsequent deficits caused by target muscle atrophy. After den-
ervation, muscle mass and contractile force rapidly decrease. The
rapid loss stabilizes at approximately 4 months, with the muscle
retaining only 25% of its mass and less than 0.1% of its maxi-
mum contractile force (reviewed in Carlson, 2004). In the early
period after denervation, satellite cells are activated, proliferate,
and form new muscle. However, these fibers are morphologically
abnormal, small in size, and do not have satellite cells associated
with them (Borisov et al., 2005). Finally, after prolonged dener-
vation, the overall number of satellite cells present in the muscle
decreases, and the capillary bed degenerates (Borisov et al., 2000;
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Jejurikar et al., 2002). This phenotype is not surprising given the
known dependence of developing muscle on neural input for
proper formation and gene expression (Betz et al., 1980; Harris
et al., 1989; Crews and Wigston, 1990; Fredette and Landmesser,
1991; Fernandes and Keshishian, 1998). Moreover, limb regener-
ation in amphibians, including regeneration of the limb muscles,
requires innervation (Brockes, 1984, 1987). Therefore, neuromus-
cular intercellular communication is a prime example of the com-
plex interplay of different tissues, requiring precise orchestration
for proper formation during development and in regeneration.
The changes occurring in muscles after denervation further
limit the restoration of function, even after axonal regeneration
occurs. Preventing the maladaptive changes associated with den-
ervation and reinnervating target muscles more quickly are the
major challenges confronting regenerative peripheral nerve biol-
ogy. For patients with both acute and chronic facial nerve injuries,
developing these regenerative strategies may allow for more nat-
ural facial function than our current reconstructive treatments are
capable of providing.
REGENERATION OF SKIN AFTER BURN INJURY
CLINICAL VIGNETTE
A 22-year-old man involved in an automobile accident suffered
full thickness burns to nearly the entire face, scalp, and both upper
extremities. His treatment required multiple operations, first for
debridement and cadaveric skin grafting to prepare a suitable
wound bed prior to autologous grafting (Figure 7). He subse-
quently had full and split-thickness skin grafts to the face. The
scalp had exposed bone and required grafting in two stages: first
with artificial dermis (Integra, Integra Life Sciences), then with
autologous skin.
An ideal skin replacement in the face would be thin, pliable,
similar in color, and texture to surrounding skin, have rapid and
reliable engraftment, contain all the components of the skin organ,
and undergo minimal contracture and scarring. Autologous skin
is the best option currently available, and can be used in sev-
eral forms. Local skin flaps may cover relatively small defects and
FIGURE 7 | A young man with full thickness burns of the face and scalp
(A) prior to debridement and (B) after cadaveric skin graft placement.
He required multiple operations prior to final skin grafting.
provide a good match of skin color and texture. They also do
not contract significantly. For larger defects, tissue expansion is
successful for increasing the amount of skin available for local
rearrangement, but it typically requires two operations separated
by several months to recruit adequate skin. It also requires an adja-
cent donor site with healthy unscarred skin. In more complex cases
with both skin and soft tissue deficiency, free tissue transfer of skin
with its underlying muscle or fascia will provide excellent cover-
age. In craniofacial reconstruction, skin flaps often come from a
remote location, and reconstruction suffers from poor color and
texture match. Finally, in cases such as the burn patient (Figure 7),
full or split-thickness skin grafting is the most commonly used
strategy for achieving massive amounts of skin coverage. Skin may
be harvested from local or remote donor sites and is versatile with
regards to its use on both large and small defects. The limitations of
autologous skin grafting include donor site availability, donor site
morbidity, graft loss, lack of certain dermal elements (sweat glands
and hair follicles), and scar contracture. Large burns require mul-
tiple operations and serial grafts to finally achieve wound closure,
and patients are usually left with significant deformities.
Partial thickness burns retain the components of the skin organ
that are responsible for regeneration. The skin has a robust source
of stem cells located in the basal layer of the epidermis, the bulge
of the hair follicles, and the base of sebaceous glands (Fuchs and
Nowak, 2008). Each of these stem cell compartments is capable
of forming new epidermis. Alternatives to autologous skin grafts
using cells derived from skin stem cells are cultured autologous
epidermis and autologous cell suspensions. Cultured autologous
epidermis has the advantage that small biopsies may be expanded
for large amounts of graftable epidermis. However, these grafts
contain an abnormally layered epidermis and, most importantly,
lack a dermis. Without a dermis, graft take decreases and scar for-
mation increases, making cultured autologous skin grafts inferior
to autologous skin grafts. This is because these grafts lack the elas-
tic properties of a dermal component, resulting in a much more
fragile construct, prone to sloughing (Pham et al., 2007). Autol-
ogous cell suspensions have potential to improve outcomes with
regards to skin quality, color, and rate of healing when used in par-
tial thickness burns (Wood et al., 2012). However, autologous cell
suspensions cannot be used to treat more complex full thickness
burns for the same reasons detailed above for altered epidermis.
Currently, the most significant hurdle for skin regeneration is
the regeneration of the dermis in full thickness and deep partial
thickness burns. The dermis is home to the stem cells residing in
the hair follicles and sebaceous glands. Loss of the dermis results in
an inability to regenerate. Furthermore, the dermis is responsible
for the stability of the graft and native skin, elasticity of the skin and
prevention of contracture, and important cell-extracellular matrix
interactions that are necessary for healing and homeostasis. With-
out dermis, it is not possible to obtain a stable skin construct that
will resist contracture, trauma, and infection.
To address this problem, multiple approaches have been used
to engineer artificial dermal matrices. Thus far, collagen-based
matrices appear to have better cellular integration than synthetic
polymers (reviewed in Widgerow, 2012). Artificial dermis is suc-
cessful in improving contour and graft take onto bone, cartilage,
or tendon (reviewed in Yannas et al., 2011). However, artificial
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dermis requires the use of autologous skin grafting with some
native dermis present in the graft, and does not appear to improve
long-term contracture or healing (Philandrianos et al., 2012). A
dermal matrix that also contains keratinocytes or basal stem cells
and is capable of resurfacing large wounds in one step has yet to
be developed. Developing mechanisms for regenerating dermis,
or engineering and culturing full thickness skin for grafting, will
dramatically change acute burn care. In patients with large areas
of full thickness burn in sensitive areas of the face, regenerated
skin and dermis could provide greatly improved functional and
cosmetic outcomes and allow for treatment to be completed with
fewer surgical interventions. Like other tissues, skin is complex, is
comprised of multiple cell types, is vascularized by blood vessels,
and is innervated. Skin injuries have a great capacity to heal, but
the drawbacks of healing are most evident in injuries to the skin of
the face. Scarring, deformities, and loss of function are the norm
and approaches to “replace like with like” are needed.
In addition to the acute need for skin coverage to prevent infec-
tion and fluid loss, burn patients suffer from distinct long-term
deformities, such as scar contracture that require additional oper-
ations for release. Fat grafting is one strategy that has also been
used to soften and improve the quality of scars in burn patients.
The molecular mechanisms are unclear, but fat grafting increases
the vascularity of the scar and alters its collagen content (Klinger
et al., 2008).
THE FUTURE OF REGENERATIVE STRATEGIES IN
CRANIOFACIAL DISEASES
Two general strategies are emerging as future solutions to cranio-
facial reconstructive challenges: regenerative approaches discussed
in this manuscript and composite tissue transplantation. Compos-
ite tissue transplantation has been making inroads in recent years,
with the first successful face transplant in 2005 (Devauchelle et al.,
2006). At least 18 have been performed worldwide since, including
several full face transplants (Pomahac et al., 2012). Facial allotrans-
plantation holds great promise with regards to the restoration of
form and function superior to that of traditional reconstructive
techniques. One clear advantage of facial allotransplantation is
that the complex tissues of the face are fully and normally formed
prior to transplantation. Current disadvantages include the need
for life-long immunosuppression, with the risks of developing
life-threatening infections, and unclear functional integration and
cosmetic appearance of the graft. Some facial muscle function and
sensation has been documented with facial allotransplantation,
but normalization of sensation, expression, and function has yet
to be demonstrated with long-term follow up.
Regenerative medicine approaches to regenerate individual
functional tissues based on developmental mechanisms may ulti-
mately lead to clinical composite tissue regeneration. A theoretical
advantage of this approach is the achievement of fully integrated,
complex, functional tissue that is truly “self”-derived. Many unan-
swered questions exist at this point, including whether func-
tion, appearance, and sensation may be better achieved through
regeneration of native structures rather than reinnervation of a
transplant. The regeneration of complex facial structures also
requires precision and specificity. Directing the regeneration of
cells such that they proliferate in the appropriate locations at
appropriate times, and reach terminal differentiation when the
organ is fully regenerated will be challenging. Regeneration strate-
gies will need to develop hand in hand with tissue engineering
strategies that allow us to build the components of the face
precisely.
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